Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04034225
Title Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Sensei Biotherapeutics, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.